https://youtu.be/AIjU6VtpVO4

To book media appearances contact Frank at 858.405.5653

Confirmed cases of Coronavirus infection eclipsed 85,000 worldwide over the weekend. Many people and companies are asking how this latest global infection may impact their lives and businesses. The actual facts are very different from what you may have heard on the news or at the local coffee shop. Questions that may have arisen in the minds of the employee and employer over the past several weeks and months include:

"Will a surgical mask protect my employees from contracting the virus?"

"How do I best tell fact from fiction surrounding the coronavirus?"

"How do I handle employees who have the flu-like symptoms and perhaps a respiratory infection?"

"What precautions should I take as a concerned citizen or business owner?"

"What precautions can I take with my otherwise healthy employees?"

"How do I decide when to ask my employees to come into the office or telecommute?"

"What plan can I put in place to better address the risks of infections to my business?"

"How do I handle international employees and or business contacts?"

Dr. Dave Vigerust has the answers to these questions and more related to epidemic and pandemic preparedness for your company and your employees.

He can explain the reality of this infection and future infections to your employees and you as a concerned business owner.

The benefits of booking Dr. Vigerust center around a better understanding of the risks to business and the welfare of employees. Dr. Vigerust provides a clear and rational explanation of the risks from these infections, the benefits of having a defined preparedness plan now and how to gauge the threat from future potential epidemic and pandemic emergencies.

He can define a preparedness plan that your company can follow to mitigate any business disruption but also can help inform your employees about what concerns are valid and which are overblown.

Dr. Vigerust began his career in virology and immunology 25 years ago investigating the interaction between bacterial infections and the human body. He continued studies on the interaction of HIV and influenza with the human immune system followed by additional training in respiratory infectious disease at St. Jude Children's Research Hospital and also at Vanderbilt University Medical Center.

Dr. Vigerust received a bachelor's degree in Biology and Chemistry from the University of Texas at El Paso, a master's degree in Microbiology and Immunology from Texas Tech University and a Ph.D. in Cellular and Molecular Pathology from Vanderbilt University.

He conducted post-doctoral research at St. Jude Children's Research Hospital on the effects of influenza and secondary bacterial infection on the human body.

Dr. Vigerust completed a second post-doctoral fellowship at Vanderbilt University Medical School in the Department of Pediatric Infectious Disease in the molecular biology of respiratory infections like influenza, respiratory syncytial virus and metapneumovirus.

Dr. Vigerust was a faculty member in the Pathology, Immunology and Microbiology Department at Vanderbilt University School of Medicine and a Health Research Scientist in the U.S. Department of Veteran's Affairs.

Most recently, Dr. Vigerust is the President and Chief Scientific Officer of several diagnostics laboratories focused around precision medicine, genomics and infectious disease.

Dr. Vigerust has published extensively in international journals, presented his research at national and international conferences and is an active editor and reviewer for several prominent journals.

Dr. Vigerust has developed several novel molecular diagnostic assays for the prediction of cardiovascular risk in patients with diabetes, infectious disease and cancer.

Dr. Vigerust speaks often on the subject of precision medicine and was selected as a TEDx speaker in 2016.

Dr. Vigerust currently maintains an Adjunct Assistant Professor position at Vanderbilt University Medical Center in the Department of Neurological Surgery and a Clinical Assistant Professor position with the University of Maryland, Eastern Shore School of Pharmacy.